160 related articles for article (PubMed ID: 1519604)
1. Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria.
Praga M; Hernández E; Montoyo C; Andrés A; Ruilope LM; Rodicio JL
Am J Kidney Dis; 1992 Sep; 20(3):240-8. PubMed ID: 1519604
[TBL] [Abstract][Full Text] [Related]
2. Nephrotic proteinuria without hypoalbuminemia: clinical characteristics and response to angiotensin-converting enzyme inhibition.
Praga M; Borstein B; Andres A; Arenas J; Oliet A; Montoyo C; Ruilope LM; Rodicio JL
Am J Kidney Dis; 1991 Mar; 17(3):330-8. PubMed ID: 1996578
[TBL] [Abstract][Full Text] [Related]
3. Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study.
Wilmer WA; Hebert LA; Lewis EJ; Rohde RD; Whittier F; Cattran D; Levey AS; Lewis JB; Spitalewitz S; Blumenthal S; Bain RP
Am J Kidney Dis; 1999 Aug; 34(2):308-14. PubMed ID: 10430979
[TBL] [Abstract][Full Text] [Related]
4. Low-dose angiotensin-converting-enzyme inhibitor captopril to reduce proteinuria in adult idiopathic membranous nephropathy: a prospective study of long-term treatment.
Rostoker G; Ben Maadi A; Remy P; Lang P; Lagrue G; Weil B
Nephrol Dial Transplant; 1995; 10(1):25-9. PubMed ID: 7724024
[TBL] [Abstract][Full Text] [Related]
5. Effect of the angiotensin converting enzyme inhibitor, captopril, on proteinuria in chronic glomerular disease.
Masunaga Y; Tabei K; Takeda S; Ando Y; Kusano E; Asano Y
Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):961-6. PubMed ID: 8255007
[TBL] [Abstract][Full Text] [Related]
6. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome.
Ruggenenti P; Mosconi L; Vendramin G; Moriggi M; Remuzzi A; Sangalli F; Remuzzi G
Am J Kidney Dis; 2000 Mar; 35(3):381-91. PubMed ID: 10692263
[TBL] [Abstract][Full Text] [Related]
7. Long-term benefits of the antiproteinuric effect of angiotensin-converting enzyme inhibition in nondiabetic renal disease.
Gansevoort RT; de Zeeuw D; de Jong PE
Am J Kidney Dis; 1993 Jul; 22(1):202-6. PubMed ID: 8322784
[TBL] [Abstract][Full Text] [Related]
8. Antiproteinuric effect of angiotensin-converting enzyme inhibition and C5b-9 urinary excretion in membranous glomerulonephritis.
Praga M; Paz Artal E; Hernández E; Segura J; Moreno MA; Morales JM; Rodicio JL
Nephrol Dial Transplant; 1997 Dec; 12(12):2576-9. PubMed ID: 9430854
[TBL] [Abstract][Full Text] [Related]
9. The renal functional and structural consequences of corticosteroid and angiotensin-converting enzyme inhibitor therapy in chronic puromycin aminonucleoside nephropathy.
Trachtman H; Del Pizzo R; Valderrama E; Gauthier B
Pediatr Nephrol; 1990 Sep; 4(5):501-4. PubMed ID: 2242316
[TBL] [Abstract][Full Text] [Related]
10. Add-on angiotensin receptor blocker in patients who have proteinuric chronic kidney diseases and are treated with angiotensin-converting enzyme inhibitors.
Kanno Y; Takenaka T; Nakamura T; Suzuki H
Clin J Am Soc Nephrol; 2006 Jul; 1(4):730-7. PubMed ID: 17699280
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.
Sasongko TH; Nagalla S; Ballas SK
Cochrane Database Syst Rev; 2013 Mar; (3):CD009191. PubMed ID: 23543572
[TBL] [Abstract][Full Text] [Related]
12. Antiproteinuric effect of angiotensin-converting-enzyme inhibitors in patients with primary glomerular disease and normal renal function.
Fabbri A; Cocchi R; Degli Esposti E; Lucatello A; Sturani A; Tampieri G; Fusaroli M
Nephrol Dial Transplant; 1990; 5 Suppl 1():81-3. PubMed ID: 2129469
[TBL] [Abstract][Full Text] [Related]
13. Effects of angiotensin-converting enzyme inhibitor and steroid therapy on proteinuria in FSGS: a retrospective study in a single clinic.
Stiles KP; Abbott KC; Welch PG; Yuan CM
Clin Nephrol; 2001 Aug; 56(2):89-95. PubMed ID: 11522100
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome.
Kosmadakis G; Filiopoulos V; Georgoulias C; Tentolouris N; Michail S
Scand J Urol Nephrol; 2010 Sep; 44(4):251-6. PubMed ID: 20201749
[TBL] [Abstract][Full Text] [Related]
15. [The antiproteinuric action of angiotensin-converting enzyme inhibitors in chronic glomerulonephritis and diabetic nephropathy].
Kutyrina IM; Tareeva IE; Shestakova MV; Gerasimenko OI; Zverev KV; Rogov VA; Sheremet'eva OV
Ter Arkh; 1994; 66(6):19-22. PubMed ID: 7940357
[TBL] [Abstract][Full Text] [Related]
16. [Long-term effect of angiotensin-converting inhibitors in children with proteinuria].
Camacho Díaz JA; Giménez Llort A; García García L; Jiménez González R
An Esp Pediatr; 2001 Sep; 55(3):219-24. PubMed ID: 11676896
[TBL] [Abstract][Full Text] [Related]
17. Effect of ACE inhibition by benazepril, enalapril and captopril on chronic and post exercise proteinuria.
Székács B; Vajo Z; Dachman W
Acta Physiol Hung; 1996; 84(4):361-7. PubMed ID: 9328608
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting the long-term outcomes of idiopathic membranous nephropathy.
Huh H; Lee H; Lee JP; Kim DK; Oh S; Oh YK; Kim YS; Lim CS
BMC Nephrol; 2017 Mar; 18(1):104. PubMed ID: 28347297
[TBL] [Abstract][Full Text] [Related]
19. IgA nephropathy associated with human immuno deficiency virus infection: antiproteinuric effect of captopril.
Górriz JL; Rovira E; Sancho A; Ferrer R; Paricio A; Pallardó LM
Nephrol Dial Transplant; 1997 Dec; 12(12):2796-7. PubMed ID: 9430904
[No Abstract] [Full Text] [Related]
20. Combined renin angiotensin blockade in childhood steroid-resistant nephrotic syndrome.
Supavekin S; Surapaitoolkorn W; Tancharoen W; Pattaragarn A; Sumboonnanonda A
Pediatr Int; 2012 Dec; 54(6):793-7. PubMed ID: 22621380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
